I-Corps: High Risk Patient Monitoring during Magnetic Resonance Imaging

I-Corps:磁共振成像期间的高风险患者监测

基本信息

  • 批准号:
    1617340
  • 负责人:
  • 金额:
    $ 5万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
    Standard Grant
  • 财政年份:
    2016
  • 资助国家:
    美国
  • 起止时间:
    2016-01-01 至 2017-06-30
  • 项目状态:
    已结题

项目摘要

Over 800,000 people in the US experience a stroke each year according to the Center for Disease Control and Prevention, a majority of which is severe enough to disqualify them from receiving the advanced diagnostic standard set forth by modern Magnetic Resonance Imaging (MRI), primarily due to the inability to accurately monitor patient conditions while they are inside an MRI scanner present with strong magnetic fields. This in turn degrades the ability of the overseeing physician to properly diagnose, as those high-risk patients are excluded from MRI diagnosis and follow-up treatments. This I-Corps team's proposed technology is a patient monitor which allows for continuous high quality monitoring of patient conditions during MRI scans, permitting high-risk patients to benefit from MRI for diagnostic scans and MRI image-guided treatments. For clinicians, the risk in performing new MR imaging and image-guided procedures will be greatly reduced through this product. For hospitals, MRI scanner, and life support manufacturers, their services can be expanded to a new patient group that was previously ineligible for MRI, allowing for a competitive advantage. For patients, they can access and receive a higher quality of diagnostic care, with a larger potential for the emergence of advanced diagnostic and functional MR imaging, and MRI image-guided treatments which may become new standards for patient care. MRI-compatible systems are those deemed safe for operation within the MRI scanner; typically non-magnetic, minimally conductive, and robust against the strong and rapidly switched magnetic fields present within the MRI scanner. The proposed product will be a high-fidelity, MRI-compatible 12-lead Electrocardiogram (ECG) recording system, capable of monitoring high-risk patients (e.g. being sedated and intubated), as well as low- to med-risk patients, who may require an extended MR imaging session, in which they would remain unattended within the MRI scanner. The product provides real-time diagnostic quality monitoring, previously unavailable using current technologies, while not compromising the operation and diagnostic ability of the MRI scanner. This product could greatly improve the state of patient monitoring in the MRI, which is critical for severely-ill patients, and subsequently the state of patient healthcare.
根据疾病控制和预防中心的数据,美国每年有超过80万人经历中风,其中大多数严重到足以使他们失去接受现代磁共振成像(MRI)提出的先进诊断标准的资格,主要是由于当他们在强磁场的MRI扫描仪内时无法准确监测患者状况。 这反过来又降低了监督医生正确诊断的能力,因为这些高风险患者被排除在MRI诊断和后续治疗之外。I-Corps团队提出的技术是一种患者监护仪,可以在MRI扫描期间持续高质量地监测患者状况,使高风险患者能够从MRI诊断扫描和MRI图像引导治疗中受益。 对于临床医生来说,通过该产品,将大大降低执行新的MR成像和图像引导程序的风险。 对于医院、MRI扫描仪和生命支持制造商来说,他们的服务可以扩展到以前不符合MRI条件的新患者群体,从而获得竞争优势。对于患者来说,他们可以获得并接受更高质量的诊断护理,先进的诊断和功能性MR成像以及MRI图像引导治疗的出现具有更大的潜力,这些可能成为患者护理的新标准。MRI兼容系统是指在MRI扫描仪内安全运行的系统;通常为非磁性、导电性极低,并且对MRI扫描仪内存在的强磁场和快速切换磁场具有鲁棒性。 申报产品将是一种高保真、MRI兼容的12导联心电图(ECG)记录系统,能够监测高风险患者(例如,正在接受镇静和插管)以及低至中等风险患者,这些患者可能需要延长MR成像会话,在此期间,他们将在MRI扫描仪内保持无人值守。该产品提供了实时诊断质量监测,以前使用当前技术无法实现,同时不影响MRI扫描仪的操作和诊断能力。 该产品可以极大地改善MRI中的患者监测状态,这对患有癌症的患者至关重要,并随后改善患者的医疗保健状态。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Tsz Ho Tse其他文献

Tsz Ho Tse的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Tsz Ho Tse', 18)}}的其他基金

2020 International Symposium on Medical Robotics
2020年医疗机器人国际研讨会
  • 批准号:
    1946416
  • 财政年份:
    2020
  • 资助金额:
    $ 5万
  • 项目类别:
    Standard Grant
The 5th North American Spring School on Medical Robotics
第五届北美春季医疗机器人学校
  • 批准号:
    1914492
  • 财政年份:
    2019
  • 资助金额:
    $ 5万
  • 项目类别:
    Standard Grant
I-Corps: Smartphone-based peanut maturity grading and analytic system
I-Corps:基于智能手机的花生成熟度分级和分析系统
  • 批准号:
    1949790
  • 财政年份:
    2019
  • 资助金额:
    $ 5万
  • 项目类别:
    Standard Grant
I-Corps: Radiofrequency Ablation using Wirelessly Powered Catheter and Generator
I-Corps:使用无线供电导管和发生器进行射频消融
  • 批准号:
    1836894
  • 财政年份:
    2018
  • 资助金额:
    $ 5万
  • 项目类别:
    Standard Grant

相似国自然基金

The Heterogenous Impact of Monetary Policy on Firms' Risk and Fundamentals
  • 批准号:
  • 批准年份:
    2024
  • 资助金额:
    万元
  • 项目类别:
    外国学者研究基金项目
基于时间序列间分位相依性(quantile dependence)的风险值(Value-at-Risk)预测模型研究
  • 批准号:
    71903144
  • 批准年份:
    2019
  • 资助金额:
    17.0 万元
  • 项目类别:
    青年科学基金项目
RISK通路在胃泌素介导的心脏缺血再灌注损伤保护中的作用研究
  • 批准号:
    81800239
  • 批准年份:
    2018
  • 资助金额:
    21.0 万元
  • 项目类别:
    青年科学基金项目
异氟烷基于TLR4/RISK/NF-κB调控糖尿病缺血性脑卒中后NLRP3炎症小体形成的机制研究
  • 批准号:
    81771232
  • 批准年份:
    2017
  • 资助金额:
    54.0 万元
  • 项目类别:
    面上项目
Notch1与RISK/SAFE/HIF-1α信号通路整合在I-postC保护中的作用及其机制
  • 批准号:
    81260024
  • 批准年份:
    2012
  • 资助金额:
    50.0 万元
  • 项目类别:
    地区科学基金项目

相似海外基金

Bridging the gap between environment and patient; investigating the risk and transmission of antifungal resistance in Aspergillus fumigatus
弥合环境与患者之间的差距;
  • 批准号:
    MR/Y034465/1
  • 财政年份:
    2024
  • 资助金额:
    $ 5万
  • 项目类别:
    Research Grant
Developing diagnostics of patient-specific cancer risk and early-stage tumorigenesis
开发患者特异性癌症风险和早期肿瘤发生的诊断方法
  • 批准号:
    478999
  • 财政年份:
    2023
  • 资助金额:
    $ 5万
  • 项目类别:
    Operating Grants
Understanding adverse drug reactions to dolutegravir and isoniazid in HIV-positive Ugandans: incidence, risk factors, management and patient-reporting
了解乌干达 HIV 阳性患者对多替拉韦和异烟肼的不良药物反应:发生率、危险因素、管理和患者报告
  • 批准号:
    MR/V030434/1
  • 财政年份:
    2023
  • 资助金额:
    $ 5万
  • 项目类别:
    Research Grant
CAREER: Integrative Pathway Analysis for Cancer Subtyping, Patient Stratification, and Risk Prediction
职业:癌症亚型、患者分层和风险预测的综合路径分析
  • 批准号:
    2343019
  • 财政年份:
    2023
  • 资助金额:
    $ 5万
  • 项目类别:
    Continuing Grant
Developing a Patient Navigation Intervention to Improve Risk Management among Women at High Risk of Breast Cancer
制定患者导航干预措施以改善乳腺癌高危女性的风险管理
  • 批准号:
    10593675
  • 财政年份:
    2023
  • 资助金额:
    $ 5万
  • 项目类别:
Mentorship in patient-oriented research to optimize community-based HIV prevention for adults at high-risk of HIV at alcohol drinking venues in East Africa
指导以患者为导向的研究,以优化东非饮酒场所艾滋病毒高危成年人的社区艾滋病毒预防
  • 批准号:
    10762303
  • 财政年份:
    2023
  • 资助金额:
    $ 5万
  • 项目类别:
Understanding the impact of an EHR-integrated hereditary cancer risk assessment application on patient-provider communication
了解 EHR 集成遗传性癌症风险评估应用程序对患者与提供者沟通的影响
  • 批准号:
    10831167
  • 财政年份:
    2023
  • 资助金额:
    $ 5万
  • 项目类别:
CAREER: Integrative Pathway Analysis for Cancer Subtyping, Patient Stratification, and Risk Prediction
职业:癌症亚型、患者分层和风险预测的综合路径分析
  • 批准号:
    2141660
  • 财政年份:
    2022
  • 资助金额:
    $ 5万
  • 项目类别:
    Continuing Grant
Correlating Genomic AMD Risk Variants with Lipid Composition and Phagocytic Function of Patient-Derived Induced Pluripotent Stem Cell (iPSC)-derived Retinal Pigment Epithelium (RPE)
将基因组 AMD 风险变异与患者来源的诱导多能干细胞 (iPSC) 来源的视网膜色素上皮 (RPE) 的脂质成分和吞噬功能相关联
  • 批准号:
    10701841
  • 财政年份:
    2022
  • 资助金额:
    $ 5万
  • 项目类别:
Pediatric Adverse Event Risk Reduction for High Risk Medications in Children and Adolescents: Improving Pediatric Patient Safety in Dental Practices
降低儿童和青少年高风险药物的儿科不良事件风险:提高牙科诊所中儿科患者的安全
  • 批准号:
    10676786
  • 财政年份:
    2022
  • 资助金额:
    $ 5万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了